Neuralink, founded in 2016, is a leading neurotechnology and biotechnology company based in the United States. The company is focused on developing advanced brain-machine interface technologies to create a direct connection between the human brain and computers. This groundbreaking technology aims to help people with neurological disorders, improve cognitive abilities, and eventually enable seamless communication with artificial intelligence systems.

Neuralink's core mission is to leverage its innovative neurotechnology to improve the quality of life for individuals suffering from a range of medical conditions, such as paralysis, Alzheimer’s, and other brain-related diseases. The company's ultimate goal is to integrate human consciousness with AI, potentially revolutionizing the future of human interaction and technology.